Goodrx Holdings Inc
$ 2.27
-3.40%
17 Apr - close price
- Market Cap 805,050,000 USD
- Current Price $ 2.27
- High / Low $ 2.39 / 2.25
- Stock P/E 26.11
- Book Value 1.81
- EPS 0.09
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.05 %
- 52 Week High 5.81
- 52 Week Low 1.77
About
GoodRx Holdings, Inc. provides information and tools that allow consumers to compare prices and save when buying prescription drugs in the United States. The company is headquartered in Santa Monica, California.
Analyst Target Price
$2.82
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-25 | 2025-11-04 | 2025-08-06 | 2025-05-07 | 2025-02-26 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-02-29 | 2023-11-09 | 2023-08-09 | 2023-05-10 |
| Reported EPS | 0.09 | 0.08 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.06 | 0.07 | 0.07 |
| Estimated EPS | 0.0917 | 0.09 | 0.1 | 0.0957 | 0.0959 | 0.09 | 0.09 | 0.08 | 0.07 | 0.06 | 0.06 | 0.06 |
| Surprise | -0.0017 | -0.01 | -0.01 | -0.0057 | -0.0059 | -0.01 | -0.01 | 0 | 0.01 | 0 | 0.01 | 0.01 |
| Surprise Percentage | -1.8539% | -11.1111% | -10% | -5.9561% | -6.1522% | -11.1111% | -11.1111% | 0% | 14.2857% | 0% | 16.6667% | 16.6667% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.03 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: GDRX
2026-04-16 04:09:22
Christopher A. McGinnis, an officer at GoodRx Holdings, Inc. (GDRX), exercised 36,987 restricted stock units (RSUs) into Class A common stock, with 10,745 shares withheld for tax obligations. After this transaction, McGinnis directly holds 152,563 Class A shares, and 406,865 RSUs remain outstanding, set to vest in quarterly installments starting April 15, 2026. This activity is a result of compensation-related equity vesting rather than an open-market trade.
2026-04-15 22:09:22
GoodRx Holdings, Inc. director and officer Wendy Lynn Barnes converted 277,288 restricted stock units (RSUs) into Class A common stock. To cover tax obligations, 120,456 Class A shares were disposed of at $2.23 per share through tax-withholding transactions, not open-market sales. After these transactions, Barnes directly owns 584,825 shares of Class A common stock.
2026-04-04 17:39:12
GoodRx Holdings, Inc. (NASDAQ: GDRX) has filed an 8-K current report with the SEC, announcing the resignation of director Ian T. Clark and a subsequent board realignment. CEO Wendy Barnes was reclassified from Class I to Class III director to balance the board's classes. The company stated the resignation was not due to disagreements, but investors are advised to monitor such governance changes as they can impact shareholder sentiment and potentially share price.
2026-04-04 11:40:38
GoodRx Holdings Inc. (NASDAQ:GDRX) announced changes to its board of directors following the resignation of Ian T. Clark. Wendy Barnes, the CEO, President, and Director, was transferred from Class I to Class III to rebalance the board's membership, with her term now expiring at the 2026 annual meeting. These changes ensure the board now has three directors in each class, and the company clarified that Barnes's service remains uninterrupted for all other purposes.
2026-04-03 21:10:57
GoodRx Holdings announced changes to its board of directors following the resignation of Ian T. Clark. Wendy Barnes, CEO, President, and Director, was transferred from Class I to Class III to balance the board's classes. The company also recently reported Q4 2025 earnings and updated financial guidance, leading to revised price targets from analysts and the resignation of its Chief Accounting Officer.
2026-04-03 20:09:35
GoodRx announced that Ian T. Clark resigned from its Board of Directors, effective March 31, 2026. Following his departure, Wendy Barnes was reclassified and appointed to Class III of the Board, effective April 1, 2026, to rebalance board membership. Her new term will expire in 2026, shifting from her previous Class I position.
